1
|
Papadakis E, Baryannis G, Batsakis S, Adamou M, Huang Z, Antoniou G. ADHD-KG: a knowledge graph of attention deficit hyperactivity disorder. Health Inf Sci Syst 2023; 11:52. [PMID: 38028962 PMCID: PMC10640525 DOI: 10.1007/s13755-023-00253-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2023] [Accepted: 10/14/2023] [Indexed: 12/01/2023] Open
Abstract
Purpose Attention Deficit Hyperactivity Disorder (ADHD) is a widespread condition that affects human behaviour and can interfere with daily activities and relationships. Medication or medical information about ADHD can be found in several data sources on the Web. Such distribution of knowledge raises notable obstacles since researchers and clinicians must manually combine various sources to deeply explore aspects of ADHD. Knowledge graphs have been widely used in medical applications due to their data integration capabilities, offering rich data stores of information built from heterogeneous sources; however, general purpose knowledge graphs cannot represent knowledge in sufficient detail, thus there is an increasing interest in domain-specific knowledge graphs. Methods In this work we propose a Knowledge Graph of ADHD. In particular, we introduce an automated procedure enabling the construction of a knowledge graph that covers knowledge from a wide range of data sources primarily focusing on adult ADHD. These include relevant literature and clinical trials, prescribed medication and their known side-effects. Data integration between these data sources is accomplished by employing a suite of information linking procedures, which aim to connect resources by relating them to common concepts found in medical thesauri. Results The usability and appropriateness of the developed knowledge graph is evaluated through a series of use cases that illustrate its ability to enhance and accelerate information retrieval. Conclusion The Knowledge Graph of ADHD can provide valuable assistance to researchers and clinicians in the research, training, diagnostic and treatment processes for ADHD.
Collapse
Affiliation(s)
- Emmanuel Papadakis
- School of Computing and Engineering, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH West Yorkshire UK
| | - George Baryannis
- School of Computing and Engineering, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH West Yorkshire UK
| | - Sotiris Batsakis
- School of Computing and Engineering, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH West Yorkshire UK
| | - Marios Adamou
- South West Yorkshire Partnership NHS Foundation Trust, Portobello Road, Wakefield, WF1 5PN West Yorkshire UK
| | - Zhisheng Huang
- Department of Computer Science, Vrije University of Amsterdam, De Boelelaan 1081, Amsterdam, 1081 HV Netherlands
| | - Grigoris Antoniou
- School of Computing and Engineering, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH West Yorkshire UK
| |
Collapse
|
2
|
Callahan P. Harmonizing Progress:: Bridging BioPharma, Technology, Academia, and Healthcare for Advanced Drug Manufacturing. Dela J Public Health 2023; 9:6-10. [PMID: 38173959 PMCID: PMC10759976 DOI: 10.32481/djph.2023.11.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2024] Open
Abstract
This paper proposes a quadrilateral approach to advance biopharmaceutical manufacturing by fostering collaboration among biopharma, lab informatics, healthcare systems, and academia. Through a retrospection based on Gary Pisano's analysis and real-world examples like insitro and Spark Therapeutics, we highlight the imperative of continuous process innovation and regulatory collaboration. We emphasize leveraging technological advancements, particularly in machine learning and artificial intelligence (AI), to catalyze a paradigm shift in drug manufacturing and delivery. The discussion extends to fostering academic and business partnerships, akin to Silicon Valley's ecosystem, and engaging healthcare systems in a more integrated role, exemplified by the advent of point-of-care manufacturing. The paper underscores the unique potential of the State of Delaware to propel forward the biopharma manufacturing space, advocating for a coordinated effort to translate scientific advancements into real healthcare benefits.
Collapse
Affiliation(s)
- Patrick Callahan
- Director, LabWare; Advisory Board Member, BioCurrie and Acellus Health. Head, Science and Technology Committee, Prosperity Initiative, State of Delaware
| |
Collapse
|
3
|
Khan S, Khan HU, Nazir S. Systematic analysis of healthcare big data analytics for efficient care and disease diagnosing. Sci Rep 2022; 12:22377. [PMID: 36572709 PMCID: PMC9792582 DOI: 10.1038/s41598-022-26090-5] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2022] [Accepted: 12/09/2022] [Indexed: 12/27/2022] Open
Abstract
Big data has revolutionized the world by providing tremendous opportunities for a variety of applications. It contains a gigantic amount of data, especially a plethora of data types that has been significantly useful in diverse research domains. In healthcare domain, the researchers use computational devices to extract enriched relevant information from this data and develop smart applications to solve real-life problems in a timely fashion. Electronic health (eHealth) and mobile health (mHealth) facilities alongwith the availability of new computational models have enabled the doctors and researchers to extract relevant information and visualize the healthcare big data in a new spectrum. Digital transformation of healthcare systems by using of information system, medical technology, handheld and smart wearable devices has posed many challenges to researchers and caretakers in the form of storage, minimizing treatment cost, and processing time (to extract enriched information, and minimize error rates to make optimum decisions). In this research work, the existing literature is analysed and assessed, to identify gaps that result in affecting the overall performance of the available healthcare applications. Also, it aims to suggest enhanced solutions to address these gaps. In this comprehensive systematic research work, the existing literature reported during 2011 to 2021, is thoroughly analysed for identifying the efforts made to facilitate the doctors and practitioners for diagnosing diseases using healthcare big data analytics. A set of rresearch questions are formulated to analyse the relevant articles for identifying the key features and optimum management solutions, and laterally use these analyses to achieve effective outcomes. The results of this systematic mapping conclude that despite of hard efforts made in the domains of healthcare big data analytics, the newer hybrid machine learning based systems and cloud computing-based models should be adapted to reduce treatment cost, simulation time and achieve improved quality of care. This systematic mapping will also result in enhancing the capabilities of doctors, practitioners, researchers, and policymakers to use this study as evidence for future research.
Collapse
Affiliation(s)
- Sulaiman Khan
- Department of Accounting and Information Systems, College of Business and Economics, Qatar University, Doha, Qatar
| | - Habib Ullah Khan
- Department of Accounting and Information Systems, College of Business and Economics, Qatar University, Doha, Qatar
| | - Shah Nazir
- Department of Computer Science, University of Swabi, Swabi, Pakistan
| |
Collapse
|
4
|
Rico-Uribe LA, Morillo-Cuadrado D, Rodríguez-Laso Á, Vorstenbosch E, Weser AJ, Fincias L, Marcon Y, Rodriguez-Mañas L, Haro JM, Ayuso-Mateos JL. Worldwide mapping of initiatives that integrate population cohorts. Front Public Health 2022; 10:964086. [PMID: 36262229 PMCID: PMC9574101 DOI: 10.3389/fpubh.2022.964086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2022] [Accepted: 09/14/2022] [Indexed: 11/29/2022] Open
Affiliation(s)
- Laura Alejandra Rico-Uribe
- CIBERSAM (Network-Based Biomedical Research Consortium, Area of Mental Health), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain
- School of Health Sciences, Universidad Internacional de La Rioja, Logroño, Spain
| | - Daniel Morillo-Cuadrado
- CIBERSAM (Network-Based Biomedical Research Consortium, Area of Mental Health), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain
- Instituto de Investigación Sanitaria La Princesa (IIS-LP), Hospital Universitario de La Princesa, Madrid, Spain
- *Correspondence: Daniel Morillo-Cuadrado
| | - Ángel Rodríguez-Laso
- CIBERFES (Network-Based Biomedical Research Consortium, Area of Frailty and Healthy Ageing), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain
| | - Ellen Vorstenbosch
- CIBERSAM (Network-Based Biomedical Research Consortium, Area of Mental Health), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain
- Parc Sanitari Sant Joan de Déu, Barcelona, Spain
- Department of Medicine, Universitat de Barcelona, Barcelona, Spain
| | - Andreas J. Weser
- HUNT (The Trøndelag Health Study) Research Centre, Norwegian University of Science and Technology, Trondheim, Norway
| | | | | | - Leocadio Rodriguez-Mañas
- CIBERFES (Network-Based Biomedical Research Consortium, Area of Frailty and Healthy Ageing), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain
| | - Josep María Haro
- Parc Sanitari Sant Joan de Déu, Barcelona, Spain
- Department of Medicine, Universitat de Barcelona, Barcelona, Spain
| | - José Luis Ayuso-Mateos
- CIBERSAM (Network-Based Biomedical Research Consortium, Area of Mental Health), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain
- Instituto de Investigación Sanitaria La Princesa (IIS-LP), Hospital Universitario de La Princesa, Madrid, Spain
- Department of Psychiatry, Universidad Autónoma de Madrid, Madrid, Spain
| |
Collapse
|
5
|
Federated Learning Approach to Protect Healthcare Data over Big Data Scenario. SUSTAINABILITY 2022. [DOI: 10.3390/su14052500] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The benefits and drawbacks of various technologies, as well as the scope of their application, are thoroughly discussed. The use of anonymity technology and differential privacy in data collection can aid in the prevention of attacks based on background knowledge gleaned from data integration and fusion. The majority of medical big data are stored on a cloud computing platform during the storage stage. To ensure the confidentiality and integrity of the information stored, encryption and auditing procedures are frequently used. Access control mechanisms are mostly used during the data sharing stage to regulate the objects that have access to the data. The privacy protection of medical and health big data is carried out under the supervision of machine learning during the data analysis stage. Finally, acceptable ideas are put forward from the management level as a result of the general privacy protection concerns that exist throughout the life cycle of medical big data throughout the industry.
Collapse
|
6
|
Martínez-García M, Hernández-Lemus E. Data Integration Challenges for Machine Learning in Precision Medicine. Front Med (Lausanne) 2022; 8:784455. [PMID: 35145977 PMCID: PMC8821900 DOI: 10.3389/fmed.2021.784455] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Accepted: 12/28/2021] [Indexed: 12/19/2022] Open
Abstract
A main goal of Precision Medicine is that of incorporating and integrating the vast corpora on different databases about the molecular and environmental origins of disease, into analytic frameworks, allowing the development of individualized, context-dependent diagnostics, and therapeutic approaches. In this regard, artificial intelligence and machine learning approaches can be used to build analytical models of complex disease aimed at prediction of personalized health conditions and outcomes. Such models must handle the wide heterogeneity of individuals in both their genetic predisposition and their social and environmental determinants. Computational approaches to medicine need to be able to efficiently manage, visualize and integrate, large datasets combining structure, and unstructured formats. This needs to be done while constrained by different levels of confidentiality, ideally doing so within a unified analytical architecture. Efficient data integration and management is key to the successful application of computational intelligence approaches to medicine. A number of challenges arise in the design of successful designs to medical data analytics under currently demanding conditions of performance in personalized medicine, while also subject to time, computational power, and bioethical constraints. Here, we will review some of these constraints and discuss possible avenues to overcome current challenges.
Collapse
Affiliation(s)
- Mireya Martínez-García
- Clinical Research Division, National Institute of Cardiology ‘Ignacio Chávez’, Mexico City, Mexico
| | - Enrique Hernández-Lemus
- Computational Genomics Division, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico
- Center for Complexity Sciences, Universidad Nacional Autnoma de Mexico, Mexico City, Mexico
| |
Collapse
|
7
|
Paré G, Raymond L, Pomey MP, Grégoire G, Castonguay A, Ouimet AG. Medical students’ intention to integrate digital health into their medical practice: A pre-peri COVID-19 survey study in Canada. Digit Health 2022; 8:20552076221114195. [PMID: 35898286 PMCID: PMC9309785 DOI: 10.1177/20552076221114195] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2022] [Accepted: 06/30/2022] [Indexed: 12/16/2022] Open
Abstract
Objective We aimed to explore the factors that influence medical students’ intention to
integrate dHealth technologies in their practice and analyze the influence
of the COVID-19 pandemic on their perceptions and intention. Methods We conducted a two-phased survey study at the University of Montreal's
medical school in Canada. The study population consisted of 1367 medical
students. The survey questionnaire was administered in two phases, that is,
an initial survey (t0) in February 2020, before the Covid-19
pandemic, and a replication survey (t1) in January 2021, during
the pandemic. Component-based structural equation modeling (SEM) was used to
test seven research hypotheses. Results A total of 184 students responded to the survey at t0 (13%),
whereas 138 responded to the survey at t1 (10%). Findings reveal
that students, especially those who are in their preclinical years, had
little occasion to experiment with dHealth technologies during their degree.
This lack of exposure may explain why a vast majority felt that dHealth
should be integrated into medical education. Most respondents declared an
intention to integrate dHealth, including AI-based tools, into their future
medical practice. One of the most salient differences observed between
t0 and t1 brings telemedicine to the forefront of
medical education. SEM results confirm the explanatory power of the proposed
research model. Conclusions The present study unveils the specific dHealth technologies that could be
integrated into existing medical curricula. Formal training would increase
students’ competencies with these technologies which, in turn, could ease
their adoption and effective use in their practice.
Collapse
Affiliation(s)
| | - Louis Raymond
- Université du Québec à Trois-Rivières, Trois-Rivieres, Canada
| | | | | | | | | |
Collapse
|
8
|
Huang Z, Hu Q, Liao M, Miao C, Wang C, Liu G. Knowledge Graphs of Kawasaki Disease. Health Inf Sci Syst 2021; 9:11. [PMID: 33680447 PMCID: PMC7910781 DOI: 10.1007/s13755-020-00130-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2020] [Accepted: 10/14/2020] [Indexed: 11/03/2022] Open
Abstract
Kawasaki Disease is a vasculitis syndrome that is extremely harmful to children. Kawasaki Disease can cause severe symptoms of ischemic heart disease or develop into ischemic heart disease, leading to death in children. Researchers and clinicians need to analyze various knowledge and data resources to explore aspects of Kawasaki Disease. Knowledge Graphs have become an important AI approach to integrating various types of complex knowledge and data resources. In this paper, we present an approach for the construction of Knowledge Graphs of Kawasaki Disease. It integrates a wide range of knowledge resources related to Kawasaki Disease, including clinical guidelines, clinical trials, drug knowledge bases, medical literature, and others. It provides a basic integration foundation of knowledge and data concerning Kawasaki Disease for clinical study. In this paper, we will show that this disease-specific Knowledge Graphs are useful for exploring various aspects of Kawasaki Disease.
Collapse
Affiliation(s)
- Zhisheng Huang
- Knowledge Representation and Reasoning (KR&R) Group, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
- School of Computer Science and Engineering, Wuhan University of Science and Technology, Wuhan, China
- Ztone International BV, Purmerend, The Netherlands
| | - Qing Hu
- Knowledge Representation and Reasoning (KR&R) Group, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
- School of Computer Science and Engineering, Wuhan University of Science and Technology, Wuhan, China
- Ztone International BV, Purmerend, The Netherlands
| | | | - Cong Miao
- Fujian Provincial Maternity and Children’s Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, China
| | - Chengyi Wang
- Fujian Provincial Maternity and Children’s Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, China
- Engineering Research Center for Medical Data Mining and Application of Fujian, Fujian, China
| | - Guanghua Liu
- Fujian Provincial Maternity and Children’s Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, China
| |
Collapse
|
9
|
Al Turkestani N, Bianchi J, Deleat-Besson R, Le C, Tengfei L, Prieto JC, Gurgel M, Ruellas ACO, Massaro C, Aliaga Del Castillo A, Evangelista K, Yatabe M, Benavides E, Soki F, Zhang W, Najarian K, Gryak J, Styner M, Fillion-Robin JC, Paniagua B, Soroushmehr R, Cevidanes LHS. Clinical decision support systems in orthodontics: A narrative review of data science approaches. Orthod Craniofac Res 2021; 24 Suppl 2:26-36. [PMID: 33973362 DOI: 10.1111/ocr.12492] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2021] [Revised: 04/15/2021] [Accepted: 05/04/2021] [Indexed: 12/27/2022]
Abstract
Advancements in technology and data collection generated immense amounts of information from various sources such as health records, clinical examination, imaging, medical devices, as well as experimental and biological data. Proper management and analysis of these data via high-end computing solutions, artificial intelligence and machine learning approaches can assist in extracting meaningful information that enhances population health and well-being. Furthermore, the extracted knowledge can provide new avenues for modern healthcare delivery via clinical decision support systems. This manuscript presents a narrative review of data science approaches for clinical decision support systems in orthodontics. We describe the fundamental components of data science approaches including (a) Data collection, storage and management; (b) Data processing; (c) In-depth data analysis; and (d) Data communication. Then, we introduce a web-based data management platform, the Data Storage for Computation and Integration, for temporomandibular joint and dental clinical decision support systems.
Collapse
Affiliation(s)
- Najla Al Turkestani
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA.,Department of Restorative and Aesthetic Dentistry, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia
| | - Jonas Bianchi
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA.,Department of Orthodontics, Arthur A. Dugoni School of Dentistry, University of the Pacific, San Francisco, CA, USA
| | - Romain Deleat-Besson
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA
| | - Celia Le
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA
| | - Li Tengfei
- Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA
| | - Juan Carlos Prieto
- Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA
| | - Marcela Gurgel
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA
| | - Antonio C O Ruellas
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA.,Department of Orthodontics, School of Dentistry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
| | - Camila Massaro
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA.,Department of Orthodontics, Bauru Dental School, University of São Paulo, São Paulo, Brazil
| | - Aron Aliaga Del Castillo
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA.,Department of Orthodontics, Bauru Dental School, University of São Paulo, São Paulo, Brazil
| | - Karine Evangelista
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA.,Department of Orthodontics, School of Dentistry, University of Goias, Goiania, Brazil
| | - Marilia Yatabe
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA
| | - Erika Benavides
- Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI, USA
| | - Fabiana Soki
- Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI, USA
| | - Winston Zhang
- Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
| | - Kayvan Najarian
- Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
| | - Jonathan Gryak
- Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
| | - Martin Styner
- Departments Psychiatry and Computer Science, University of North Carolina, Chapel Hill, NC, USA
| | | | | | - Reza Soroushmehr
- Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA
| | - Lucia H S Cevidanes
- Department of Orthodontics and Pediatric Dentistry, University of Michigan School of Dentistry, Ann Arbor, MI, USA
| |
Collapse
|
10
|
Borges do Nascimento IJ, Marcolino MS, Abdulazeem HM, Weerasekara I, Azzopardi-Muscat N, Gonçalves MA, Novillo-Ortiz D. Impact of Big Data Analytics on People's Health: Overview of Systematic Reviews and Recommendations for Future Studies. J Med Internet Res 2021; 23:e27275. [PMID: 33847586 PMCID: PMC8080139 DOI: 10.2196/27275] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2021] [Revised: 02/19/2021] [Accepted: 03/24/2021] [Indexed: 12/17/2022] Open
Abstract
Background Although the potential of big data analytics for health care is well recognized, evidence is lacking on its effects on public health. Objective The aim of this study was to assess the impact of the use of big data analytics on people’s health based on the health indicators and core priorities in the World Health Organization (WHO) General Programme of Work 2019/2023 and the European Programme of Work (EPW), approved and adopted by its Member States, in addition to SARS-CoV-2–related studies. Furthermore, we sought to identify the most relevant challenges and opportunities of these tools with respect to people’s health. Methods Six databases (MEDLINE, Embase, Cochrane Database of Systematic Reviews via Cochrane Library, Web of Science, Scopus, and Epistemonikos) were searched from the inception date to September 21, 2020. Systematic reviews assessing the effects of big data analytics on health indicators were included. Two authors independently performed screening, selection, data extraction, and quality assessment using the AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews 2) checklist. Results The literature search initially yielded 185 records, 35 of which met the inclusion criteria, involving more than 5,000,000 patients. Most of the included studies used patient data collected from electronic health records, hospital information systems, private patient databases, and imaging datasets, and involved the use of big data analytics for noncommunicable diseases. “Probability of dying from any of cardiovascular, cancer, diabetes or chronic renal disease” and “suicide mortality rate” were the most commonly assessed health indicators and core priorities within the WHO General Programme of Work 2019/2023 and the EPW 2020/2025. Big data analytics have shown moderate to high accuracy for the diagnosis and prediction of complications of diabetes mellitus as well as for the diagnosis and classification of mental disorders; prediction of suicide attempts and behaviors; and the diagnosis, treatment, and prediction of important clinical outcomes of several chronic diseases. Confidence in the results was rated as “critically low” for 25 reviews, as “low” for 7 reviews, and as “moderate” for 3 reviews. The most frequently identified challenges were establishment of a well-designed and structured data source, and a secure, transparent, and standardized database for patient data. Conclusions Although the overall quality of included studies was limited, big data analytics has shown moderate to high accuracy for the diagnosis of certain diseases, improvement in managing chronic diseases, and support for prompt and real-time analyses of large sets of varied input data to diagnose and predict disease outcomes. Trial Registration International Prospective Register of Systematic Reviews (PROSPERO) CRD42020214048; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=214048
Collapse
Affiliation(s)
- Israel Júnior Borges do Nascimento
- School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.,Department of Medicine, School of Medicine, Medical College of Wisconsin, Wauwatosa, WI, United States
| | - Milena Soriano Marcolino
- Department of Internal Medicine, University Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.,School of Medicine and Telehealth Center, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | | | - Ishanka Weerasekara
- School of Health Sciences, Faculty of Health and Medicine, The University of Newcastle, Callaghan, Australia.,Department of Physiotherapy, Faculty of Allied Health Sciences, University of Peradeniya, Peradeniya, Sri Lanka
| | - Natasha Azzopardi-Muscat
- Division of Country Health Policies and Systems, World Health Organization, Regional Office for Europe, Copenhagen, Denmark
| | - Marcos André Gonçalves
- Department of Computer Science, Institute of Exact Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - David Novillo-Ortiz
- Division of Country Health Policies and Systems, World Health Organization, Regional Office for Europe, Copenhagen, Denmark
| |
Collapse
|
11
|
Delpierre C, Kelly-Irving M. Big Data and the Study of Social Inequalities in Health: Expectations and Issues. Front Public Health 2018; 6:312. [PMID: 30416994 PMCID: PMC6212467 DOI: 10.3389/fpubh.2018.00312] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2018] [Accepted: 10/10/2018] [Indexed: 11/13/2022] Open
Abstract
Understanding the construction of the social gradient in health is a major challenge in the field of social epidemiology, a branch of epidemiology that seeks to understand how society and its different forms of organization influence health at a population level. Attempting to answer these questions involves large datasets of varied heterogeneous data suggesting that Big Data approaches could be then particularly relevant to the study of social inequalities in health. Nevertheless, real challenges have to be addressed in order to make the best use of the development of Big Data in health for the benefit of all. The main purpose of this perspective is to discuss some of these challenges, in particular: (i) the perimeter and the particularity of Big Data in health, which must be broader than a vision centerd solely on care, the individual and his or her biological characteristics; (ii) the need for clarification regarding the notion of data, the validity of data and the question of causal inference for various actors involved in health, such data as researchers, health professionals and the civilian population; (iii) the need for regulation and control of data and their uses by public authorities for the common good and the fight against social inequalities in health. To face these issues, it seems essential to integrate different approaches into a close dialog, integrating methodological, societal, and ethical issues. This question cannot escape an interdisciplinary approach, including users or patients.
Collapse
Affiliation(s)
- Cyrille Delpierre
- Inserm, UMR1027, Université Toulouse III, Toulouse, France.,Institut Fédératif d'études et de Recherches Interdisciplinaires Santé Société (Iferiss), Toulouse, France
| | - Michelle Kelly-Irving
- Inserm, UMR1027, Université Toulouse III, Toulouse, France.,Institut Fédératif d'études et de Recherches Interdisciplinaires Santé Société (Iferiss), Toulouse, France
| |
Collapse
|
12
|
Iyamu T, Mgudlwa S. Transformation of healthcare big data through the lens of actor network theory. INTERNATIONAL JOURNAL OF HEALTHCARE MANAGEMENT 2017. [DOI: 10.1080/20479700.2017.1397340] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Tiko Iyamu
- Department of Information Technology, Faculty of Informatics and Design, Cape Peninsula University of Technology, Cape Town, South Africa
| | - Sibulela Mgudlwa
- Department of Information Technology, Faculty of Informatics and Design, Cape Peninsula University of Technology, Cape Town, South Africa
| |
Collapse
|
13
|
Reporting Data Quality Assessment Results: Identifying Individual and Organizational Barriers and Solutions. EGEMS 2017; 5:16. [PMID: 29881736 PMCID: PMC5982990 DOI: 10.5334/egems.214] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Introduction: Electronic health record (EHR) data are known to have significant data quality issues, yet the practice and frequency of assessing EHR data is unknown. We sought to understand current practices and attitudes towards reporting data quality assessment (DQA) results by data professionals. Methods: The project was conducted in four Phases: (1) examined current DQA practices among informatics/CER stakeholders via engagement meeting (07/2014); (2) characterized organizations conducting DQA by interviewing key personnel and data management professionals (07-08/2014); (3) developed and administered an anonymous survey to data professionals (03-06/2015); and (4) validated survey results during a follow-up informatics/CER stakeholder engagement meeting (06/2016). Results: The first engagement meeting identified the theme of unintended consequences as a primary barrier to DQA. Interviewees were predominantly medical groups serving distributed networks with formalized DQAs. Consistent with the interviews, most survey (N=111) respondents utilized DQA processes/programs. A lack of resources and clear definitions of how to judge the quality of a dataset were the most commonly cited individual barriers. Vague quality action plans/expectations and data owners not trained in problem identification and problem-solving skills were the most commonly cited organizational barriers. Solutions included allocating resources for DQA, establishing standards and guidelines, and changing organizational culture. Discussion: Several barriers affecting DQA and reporting were identified. Community alignment towards systematic DQA and reporting is needed to overcome these barriers. Conclusion: Understanding barriers and solutions to DQA reporting is vital for establishing trust in the secondary use of EHR data for quality improvement and the pursuit of personalized medicine.
Collapse
|
14
|
Lyu KX, Zhao J, Wang B, Xiong GX, Yang WQ, Liu QH, Zhu XL, Sun W, Jiang AY, Wen WP, Lei WB. Smartphone Application WeChat for Clinical Follow-up of Discharged Patients with Head and Neck Tumors: A Randomized Controlled Trial. Chin Med J (Engl) 2017; 129:2816-2823. [PMID: 27900995 PMCID: PMC5146789 DOI: 10.4103/0366-6999.194635] [Citation(s) in RCA: 60] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Background: Nowadays, social media tools such as short message service, Twitter, video, and web-based systems are more and more used in clinical follow-up, making clinical follow-up much more time- and cost-effective than ever before. However, as the most popular social media in China, little is known about the utility of smartphone WeChat application in follow-up. In this study, we aimed to investigate the feasibility and superiority of WeChat application in clinical follow-up. Methods: A total of 108 patients diagnosed with head and neck tumor were randomized to WeChat follow-up (WFU) group or telephone follow-up (TFU) group for 6-month follow-up. The follow-ups were delivered by WeChat or telephone at 2 weeks, 1, 2, 3, and 6 months to the patients after being discharged. The study measurements were time consumption for follow-up delivery, total economic cost, lost-to-follow-up rate, and overall satisfaction for the follow-up method. Results: Time consumption in WFU group for each patient (23.36 ± 6.16 min) was significantly shorter than that in TFU group (42.89 ± 7.15 min) (P < 0.001); total economic cost in WFU group (RMB 90 Yuan) was much lower than that in TFU group (RMB 196 Yuan). Lost-to-follow-up rate in the WFU group was 7.02% (4/57) compared with TFU group, 9.80% (5/51), while no significance was observed (95% confidence interval [CI]: 0.176–2.740; P = 0.732). The overall satisfaction rate in WFU group was 94.34% (50/53) compared with 80.43% (37/46) in TFU group (95% CI: 0.057–0.067; P = 0.034). Conclusions: The smartphone WeChat application was found to be a viable option for follow-up in discharged patients with head and neck tumors. WFU was time-effective, cost-effective, and convenient in communication. This doctor-led follow-up model has the potential to establish a good physician-patient relationship by enhancing dynamic communications and providing individual health instructions. Trial Registration: Chinese Clinical Trial Registry, ChiCTR-IOR-15007498; http://www.chictr.org.cn/ showproj.aspx?proj=12613.
Collapse
Affiliation(s)
- Ke-Xing Lyu
- Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
| | - Jing Zhao
- Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
| | - Bin Wang
- Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
| | - Guan-Xia Xiong
- Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
| | - Wei-Qiang Yang
- Department of Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China
| | - Qi-Hong Liu
- Department of Otorhinolaryngology, Affiliated Futian Hospital of Guangdong Medical College, Shenzhen, Guangdong 518033, China
| | - Xiao-Lin Zhu
- Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
| | - Wei Sun
- Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
| | - Ai-Yun Jiang
- Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
| | - Wei-Ping Wen
- Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
| | - Wen-Bin Lei
- Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
| |
Collapse
|
15
|
Big genomics and clinical data analytics strategies for precision cancer prognosis. Sci Rep 2016; 6:36493. [PMID: 27819294 PMCID: PMC5098145 DOI: 10.1038/srep36493] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2016] [Accepted: 10/12/2016] [Indexed: 01/08/2023] Open
Abstract
The field of personalized and precise medicine in the era of big data analytics is growing rapidly. Previously, we proposed our model of patient classification termed Prognostic Signature Vector Matching (PSVM) and identified a 37 variable signature comprising 36 let-7b associated prognostic significant mRNAs and the age risk factor that stratified large high-grade serous ovarian cancer patient cohorts into three survival-significant risk groups. Here, we investigated the predictive performance of PSVM via optimization of the prognostic variable weights, which represent the relative importance of one prognostic variable over the others. In addition, we compared several multivariate prognostic models based on PSVM with classical machine learning techniques such as K-nearest-neighbor, support vector machine, random forest, neural networks and logistic regression. Our results revealed that negative log-rank p-values provides more robust weight values as opposed to the use of other quantities such as hazard ratios, fold change, or a combination of those factors. PSVM, together with the classical machine learning classifiers were combined in an ensemble (multi-test) voting system, which collectively provides a more precise and reproducible patient stratification. The use of the multi-test system approach, rather than the search for the ideal classification/prediction method, might help to address limitations of the individual classification algorithm in specific situation.
Collapse
|
16
|
Abstract
Systems pharmacology aims to holistically understand mechanisms of drug actions to support drug discovery and clinical practice. Systems pharmacology modeling (SPM) is data driven. It integrates an exponentially growing amount of data at multiple scales (genetic, molecular, cellular, organismal, and environmental). The goal of SPM is to develop mechanistic or predictive multiscale models that are interpretable and actionable. The current explosions in genomics and other omics data, as well as the tremendous advances in big data technologies, have already enabled biologists to generate novel hypotheses and gain new knowledge through computational models of genome-wide, heterogeneous, and dynamic data sets. More work is needed to interpret and predict a drug response phenotype, which is dependent on many known and unknown factors. To gain a comprehensive understanding of drug actions, SPM requires close collaborations between domain experts from diverse fields and integration of heterogeneous models from biophysics, mathematics, statistics, machine learning, and semantic webs. This creates challenges in model management, model integration, model translation, and knowledge integration. In this review, we discuss several emergent issues in SPM and potential solutions using big data technology and analytics. The concurrent development of high-throughput techniques, cloud computing, data science, and the semantic web will likely allow SPM to be findable, accessible, interoperable, reusable, reliable, interpretable, and actionable.
Collapse
Affiliation(s)
- Lei Xie
- Department of Computer Science, Hunter College, The City University of New York, New York, NY 10065; .,The Graduate Center, The City University of New York, New York, NY 10016
| | - Eli J Draizen
- National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894; .,Program in Bioinformatics, Boston University, Boston, Massachusetts 02215
| | - Philip E Bourne
- National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894; .,Office of the Director, National Institutes of Health, Bethesda, Maryland 20894
| |
Collapse
|
17
|
Lang SJ, Böhringer D, Reinhard T. [Freiburg keratoconus registry : Example of application of smart data for clinical research and inititial results]. Ophthalmologe 2016; 113:457-62. [PMID: 27251331 DOI: 10.1007/s00347-016-0273-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
BACKGROUND Keratoconus is a progressive corneal disease with thinning and scarring of the cornea. Diagnostic and treatment options are usually evaluated in large prospective or retrospective trials. Big data and smart data provide the possibility to analyze routine data for clinical research. In this article we report the generation of a monocentric keratoconus registry by means of computerized data analysis of routine data. This demonstrates the potential of clinical research by means of routine data. METHODS A "clinical data warehouse" was created from all available routine electronic data. At the time of first presentation, each eye was classified into one out of four categories: suspected, early disease, late disease and status postkeratoplasty. Through integration of multiple data sources the clinical course for each patient was documented in the registry. RESULTS A total of 3681 eyes from 1841 patients were included. The median follow-up time was 0.54 years. Patient age was higher in the groups with more severe stages of keratoconus, the proportion of female patients was higher in the group of suspected keratoconus and patient age and male to female ratios showed statistically significant differences between the groups (p < 0.001). CONCLUSION We were able to create a "clinical data warehouse" by linking multiple data sources and normalizing the data. With this tool we established a novel, monocentric keratoconus registry. Only the grading of disease severity and the exclusion of false positive results were carried out manually. In our opinion establishing a structured clinical data warehouse has a huge potential for clinical and retrospective studies and proves the value of the Smart Data concept.
Collapse
Affiliation(s)
- S J Lang
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg, Killianstr. 5, 79106, Freiburg, Deutschland.
| | - D Böhringer
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg, Killianstr. 5, 79106, Freiburg, Deutschland
| | - T Reinhard
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg, Killianstr. 5, 79106, Freiburg, Deutschland
| |
Collapse
|
18
|
Alemayehu D, Berger ML. Big Data: transforming drug development and health policy decision making. HEALTH SERVICES AND OUTCOMES RESEARCH METHODOLOGY 2016; 16:92-102. [PMID: 27594803 PMCID: PMC4987387 DOI: 10.1007/s10742-016-0144-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2015] [Revised: 02/04/2016] [Accepted: 02/24/2016] [Indexed: 11/03/2022]
Abstract
The explosion of data sources, accompanied by the evolution of technology and analytical techniques, has created considerable challenges and opportunities for drug development and healthcare resource utilization. We present a systematic overview these phenomena, and suggest measures to be taken for effective integration of the new developments in the traditional medical research paradigm and health policy decision making. Special attention is paid to pertinent issues in emerging areas, including rare disease drug development, personalized medicine, Comparative Effectiveness Research, and privacy and confidentiality concerns.
Collapse
Affiliation(s)
| | - Marc L. Berger
- Pfizer Inc., 235 East 42nd Street, New York, NY 10017 USA
| |
Collapse
|
19
|
Rosa C, Campbell ANC, Miele GM, Brunner M, Winstanley EL. Using e-technologies in clinical trials. Contemp Clin Trials 2015; 45:41-54. [PMID: 26176884 PMCID: PMC4648297 DOI: 10.1016/j.cct.2015.07.007] [Citation(s) in RCA: 89] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2015] [Revised: 06/26/2015] [Accepted: 07/05/2015] [Indexed: 02/03/2023]
Abstract
Clinical trials have been slow to incorporate e-technology (digital and electronic technology that utilizes mobile devices or the Internet) into the design and execution of studies. In the meantime, individuals and corporations are relying more on electronic platforms and most have incorporated such technology into their daily lives. This paper provides a general overview of the use of e-technologies in clinical trials research, specifically within the last decade, marked by rapid growth of mobile and Internet-based tools. Benefits of and challenges to the use of e-technologies in data collection, recruitment and retention, delivery of interventions, and dissemination are provided, as well as a description of the current status of regulatory oversight of e-technologies in clinical trials research. As an example of ways in which e-technologies can be used for intervention delivery, a summary of e-technologies for treatment of substance use disorders is presented. Using e-technologies to design and implement clinical trials has the potential to reach a wide audience, making trials more efficient while also reducing costs; however, researchers should be cautious when adopting these tools given the many challenges in using new technologies, as well as threats to participant privacy/confidentiality. Challenges of using e-technologies can be overcome with careful planning, useful partnerships, and forethought. The role of web- and smartphone-based applications is expanding, and the increasing use of those platforms by scientists and the public alike make them tools that cannot be ignored.
Collapse
Affiliation(s)
- Carmen Rosa
- National Institutes of Health, National Institute on Drug Abuse, Bethesda, MD, USA.
| | - Aimee N C Campbell
- New York State Psychiatric Institute, Department of Psychiatry, Columbia University Medical Center, New York, NY, USA; Mount Sinai St. Luke's Hospital Department of Psychiatry and Behavioral Health, New York, NY, USA.
| | - Gloria M Miele
- Columbia University College of Physicians and Surgeons, Department of Psychiatry, New York, NY, USA.
| | - Meg Brunner
- Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA, USA.
| | - Erin L Winstanley
- The James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA.
| |
Collapse
|
20
|
Ma C, Smith HW, Chu C, Juarez DT. Big data in pharmacy practice: current use, challenges, and the future. INTEGRATED PHARMACY RESEARCH AND PRACTICE 2015; 4:91-99. [PMID: 29354523 PMCID: PMC5741030 DOI: 10.2147/iprp.s55862] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Pharmacy informatics is defined as the use and integration of data, information, knowledge, technology, and automation in the medication-use process for the purpose of improving health outcomes. The term "big data" has been coined and is often defined in three V's: volume, velocity, and variety. This paper describes three major areas in which pharmacy utilizes big data, including: 1) informed decision making (clinical pathways and clinical practice guidelines); 2) improved care delivery in health care settings such as hospitals and community pharmacy practice settings; and 3) quality performance measurement for the Centers for Medicare and Medicaid and medication management activities such as tracking medication adherence and medication reconciliation.
Collapse
Affiliation(s)
- Carolyn Ma
- Department of Pharmacy Practice, The Daniel K Inouye College of Pharmacy, University of Hawai‘i at Hilo, Hilo, HI, USA
| | - Helen Wong Smith
- Department of Pharmacy Practice, The Daniel K Inouye College of Pharmacy, University of Hawai‘i at Hilo, Hilo, HI, USA
| | - Cherie Chu
- Department of Pharmacy Practice, The Daniel K Inouye College of Pharmacy, University of Hawai‘i at Hilo, Hilo, HI, USA
| | - Deborah T Juarez
- Department of Pharmacy Practice, The Daniel K Inouye College of Pharmacy, University of Hawai‘i at Hilo, Hilo, HI, USA
| |
Collapse
|